The 340B rebate pilot was to have gone into effect on January 1. The American Hospital Association and other groups sued to ...

Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.

The 340B program is criticized for generating revenue rather than solely aiding underinsured patients, impacting community providers and Medicare patients. Pharmaceutical companies face challenges ...

The use of targeted therapy was similar between patients living in areas with the highest 340B penetration and patients living in areas with the lowest 340B penetration. Participation in the 340B Drug ...